Back
11
Day Range
$5.12
$5.15
52-Week Range
$2.22
$5.19
Volume
10,313,387
50D / 200D Avg
$4.38
/
$3.28
Prev Close
$5.14
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 110.0 | 0.3 |
| P/B | 7.3 | 2.9 |
| ROE % | 6.7 | 3.7 |
| Net Margin % | 3.4 | 3.8 |
| Rev Growth 5Y % | 19.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$5.42
+5.7%
Low: $5.00
High: $6.00
Forward P/E
37.9
Forward EPS
$0.14
EPS Growth (est.)
+0.0%
Est. Revenue
280 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.58
$0.57 – $0.59
|
600 M | 1 |
| FY2029 |
$0.41
$0.40 – $0.42
|
490 M | 1 |
| FY2028 |
$0.32
$0.31 – $0.32
|
410 M | 2 |
Key Takeaways
Revenue grew 19.12% annually over 5 years — strong growth
Earnings grew 578.83% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -2.11M
P/E of 109.98 — premium valuation
PEG of 0.13 suggests growth is underpriced
Growth
Revenue Growth (5Y)
19.12%
Revenue (1Y)22.00%
Earnings (1Y)578.83%
FCF Growth (3Y)N/A
Quality
Return on Equity
6.65%
ROIC2.02%
Net Margin3.40%
Op. Margin1.38%
Safety
Debt / Equity
0.00
Current Ratio6.38
Interest Coverage0.00
Valuation
P/E Ratio
109.98
P/B Ratio7.32
EV/EBITDA260.07
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.00% | Revenue Growth (3Y) | 23.51% |
| Earnings Growth (1Y) | 578.83% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 228.87M | Net Income (TTM) | 7.79M |
| ROE | 6.65% | ROA | 5.78% |
| Gross Margin | 42.97% | Operating Margin | 1.38% |
| Net Margin | 3.40% | Free Cash Flow (TTM) | -2.11M |
| ROIC | 2.02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 6.38 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 109.98 | P/B Ratio | 7.32 |
| P/S Ratio | 3.74 | PEG Ratio | 0.13 |
| EV/EBITDA | 260.07 | Dividend Yield | 0.00% |
| Market Cap | 857.10M | Enterprise Value | 819.75M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 228.87M | 187.59M | 150.05M | 119.57M | 113.67M |
| Net Income | 7.79M | 1.15M | -19.18M | -79.67M | -62.74M |
| EPS (Diluted) | 0.04 | 0.01 | -0.12 | -0.51 | -0.72 |
| Gross Profit | 98.35M | 85.84M | 74.38M | 60.34M | 66.77M |
| Operating Income | 3.15M | -4.50M | -23.21M | -77.02M | -93.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 134.86M | 138.68M | 142.22M | 156.25M | 223.61M |
| Total Liabilities | 17.85M | 21.28M | 23.58M | 28.72M | 31.33M |
| Shareholders' Equity | 117.02M | 117.40M | 118.65M | 127.54M | 192.27M |
| Total Debt | 0.0 | 0.0 | 0.0 | 500,000.0 | 0.0 |
| Cash & Equivalents | 37.35M | 76.69M | 123.91M | 138.55M | 198.26M |
| Current Assets | 111.06M | 130.18M | 139.80M | 152.56M | 213.33M |
| Current Liabilities | 17.40M | 19.02M | 21.65M | 27.32M | 27.18M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#142 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026